Official data from INPI

122023006095

Em AnáliseUtility ModelPCT · US2014060477

Talk to an expert

Application data

Number

122023006095

Type

Utility Model

Filing

10/14/2014

Publication

PCT

US2014060477

View on INPI

Progress at the INPI

Under appeal

Filing10/14/14
Publication
Examination
Allowance
Grant
In force

The application is under appeal: the INPI has yet to review the decision.

Latest action published by the INPI: 10/31/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SEAGEN INC.

See this company's full portfolio

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Petição de recurso

#12.2

Recurso: 870230093370 - 20/10/2023

10/31/2023

RPI 2756

Indeferimento

#9.2

08/22/2023

RPI 2746

Notificação de pedido dividido

#2.4

05/02/2023

RPI 2730

Requerimento de pedido de patente

#2.10

Número de Protocolo '870230027307' em 31/03/2023 13:33 (WB)

04/11/2023

RPI 2727

From the same holder

112026019338 112026018937 112026006340 CONJUGADOS ANTICORPO-FÁRMACO DE CEACAM5 E MÉTODOS DE USO DOS MESMOS USO DE UM CONJUGADO ANTICORPO-FÁRMACO QUE SE LIGA A ALFA-V-BETA-6, E KIT COMPREENDENDO O MESMO PROTEÍNA DE FUSÃO ESPECÍFICA PARA CD137 E CD228 ANTICORPOS QUE SE LIGAM À CD228 COMPOSTOS CITOTÓXICOS, COMPOSTOS CITOTÓXICOS DE FÁRMACO-LIGANTE, CONJUGADOS DOS MESMOS, COMPOSIÇÃO FARMACÊUTICA E SEUS USOS

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.